 You know we have another great summit, we have great speakers, great scientists, and these people's researchers spend hours, weeks, years of their life at the basic science level in a lab, and I think most of them, if you would interview most of them or talk to them, their real dream is to have an impact clinically, and that's why we talk about clinical translation. And then, you know, you say, oh well that's one of your issues, well maybe I'll put more effort on that part of my project and we'll have an answer for you maybe in the next meeting, and then you can start thinking about using it clinically. So I think it's so important to understand that all the efforts that are being made here is to solve medical issues and win the space of sports medicine, reserve medicine, aging better. As we age, as you know, we have problems with our muscles, with our joints, then, you know, other problems, cognitive dysfunction like Alzheimer's. So I think understanding the key questions better, combining the bench scientists and the clinician is the best way to go and collaboration, as you can see, we have great minds from Northwestern, from Mayo, from Wisconsin, from Vale. So, so having all of us in the same room, and having this discussion and presenting our work will hopefully lead to solution to these clinical problems that we see and therefore the importance of clinical translation, because at the end of the day, we want, all of us want to age better. If we get injured, we want to heal faster, to return to our active lifestyle. So I really think that all these tremendous scientists have a focused goal of understanding better how their work will impact us clinically, will help them maybe provide an answer to these question-faster and endpoint question-fasters that have a clinical implication.